Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
PHASE2
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
PHASE2
The purpose of this study is to learn about the effects of three study medi...
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
PHASE1
This is a multicenter, open-label study conducted in two phases: Phase 1 co...